20. Influenza Virus Research Center

2018.
7.

1.

2.

Uda K, Shoji K, Koyama-Wakai C, Furuichi M, Iwase

Fujisaki S, Shirakura M, Miura H, Nakamura K,N, Fujisaki S, Watanabe S, Miyairi I. Clinical

Kishida N, Kuwahara T, Mitamura K, Abe T, Ichikawa

characteristics

lower

M, Yamazaki M, Watanabe S, Odagiri T, The Influenza

respiratory infection during the 2015 to 2016 season. J

Virus Surveillance Group of Japan. Detection ofInfect Chemother. 24:407-413, 2018.

influenzaYoshihara K, Le MN, Toizumi M, Nguyen HA, Vo HM,

susceptibility to the novel cap-dependent endonuclease

Odagiri T, Fujisaki S, Ariyoshi K, Moriuchi H,inhibitor baloxavir in Japan, December 2018. Euro

Hashizume M, Dang DA, Yoshida LM. Influenza B

Surveill. 24:1800698, 2019.

associated3.

ofinfluenza

paediatricacutevirus-induced

respiratory

infection

exhibiting

reducedTakashita E, Kawakami C, Ogawa R, Morita H,

Respir Viruses. 13:248-261, 2019.

Kishida N, Kuwahara T, Ota A, Togashi H, Saito A,Kawakami C, Yamayoshi S, Akimoto M, Nakamura K,Mitamura K, Abe T, Ichikawa M, Yamazaki M,

Miura H, Fujisaki S, Pattinson DJ, Shimizu K, Ozawa

Watanabe S, Odagiri T. Influenza A(H3N2) virus

H, Momoki T, Saikusa M, Yasuhara A, Usuku S, Okubo

exhibiting reduced susceptibility to baloxavir due to aI, Toyozawa T, Sugita S, Smith DJ, Watanabe S,

polymerase acidic subunit I38T substitution detected

Kawaoka Y. Genetic and antigenic characterisation offrom a hospitalised child without prior baloxavir

influenza A(H3N2) viruses isolated in Yokohamatreatment,

during the 2016/17 and 2017/18 influenza seasons.

24:1900170, 2019.
9.

Japan,January

2019.

EuroSurveill.

Tanikawa T, Uchida Y, Takemae N, Tsunekuni R, Mine

Kuwahara T, Takashita E, Fujisaki S, Shirakura M,J, Liu MT, Yang JR, Shirakura M, Watanabe S, Odagiri

Nakamura K, Kishida N, Takahashi H, Suzuki N,T, Saito T. Pathogenicity of two novel human-origin

Kawaoka Y, Watanabe S, Odagiri T. Isolation of an

H7N9 highly pathogenic avian influenza viruses in

Egg-Adapted Influenza A(H3N2) Virus without Amino

chickens and ducks. Arch Virol. 164: 535-545, 2018.
10.

Shibata A, Harada R, Okamatsu M, Matsuno K, Arita T,Hemagglutinin. Jpn J Infect Dis. 71:234-238, 2018.

Suzuki Y, Shirakura M, Odagiri T, Takemae N, Uchida

Lackenby A, Besselaar TG, Daniels RS, Fry A,Y, Saito T, Sakoda Y, Osaka H. Characterization of a

Gregory V, Gubareva LV, Huang W, Hurt AC, Leang

novel reassortant H7N3 highly pathogenic avian

SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiriinfluenza virus isolated from a poultry meat product

T, Pereyaslov D, Takashita E, Wang D, Zhang W,

taken on a passenger flight to Japan. J Vet Med Sci. 81:

Meijer A. Global update on the susceptibility of human444-448, 2019.

influenza viruses to neuraminidase inhibitors and statusof6.

viruses

Fujisaki S, Shirakura M, Miura H, Nakamura K,Acid Substitutions at the Antigenic Sites of Its

5.

8.

A(H3N2)

hospitalization in central vietnam. Influenza OtherEuro Surveill. 24, 2019.
4.

Takashita E, Kawakami C, Morita H, Ogawa R,novel

antivirals,

2016-2017.

Antiviral

11.

Res.

Ackerman EE, Kawakami E, Katoh M, Watanabe T,
Watanabe S, Tomita Y, Lopes TJ, Matsuoka Y, Kitano

157:38-46, 2018.

H, Shoemaker JE, Kawaoka Y. Network-Guided

Takashita E, Morita H, Ogawa R, Nakamura K,

Discovery of Influenza Virus Replication Host Factors.

Fujisaki S, Shirakura M, Kuwahara T, Kishida N,

MBio. 9: e02002-18, 2018.

Watanabe S, Odagiri T. Susceptibility of Influenza

12.

Saito S, Nakauchi M, Takayama I, Nagata S, Odagiri T,Viruses to the Novel Cap-Dependent Endonuclease

Kageyama T. Development and evaluation of new

Inhibitor Baloxavir Marboxil. Front Microbiol. 9:3026,real-time RT-PCR assays for identifying the influenza Avirus Cluster IV H3N2 variant. Jpn J Infect Dis.
25;72(2):127-129, 2019.
13.

19.

Comparison of the Filter Efficiency of Medical

Odagiri T, Kageyama T. Development and evaluation

Nonwoven Fabrics against Three Different Microbeof a new real-time RT-PCR assay for detecting theAerosols. Biocontrol Sci., 23, p61-69, 2018.

2019.

from influenza A/H1N1pdm09 virus challenge

Saito S, Sano K, Suzuki T, Ainai A, Taga Y, Ueno T,

infection via high avidity serum antibodies induced byTabata K, Saito K, Wada Y, Ohara Y, Takeyama H,

booster immunizations with inactivated whole virus

Odagiri T, Kageyama T, Ogawa-Goto K, Multihartina P,vaccine. Heliyon 5 (2019) e01113, 2018.
Hitoshi Takahashi, Shiho Nagata, Takato Odagiri,
Tsutomu Kageyama. Establishment of the cross-clade

potency of functionality of anti-influenza virus broadly

antigen detection system for H5 subtype influenza

neutralizing antibody. PLoS Pathog. 3;15(1):e1007427,

viruses using peptide monoclonal antibodies specific2019.

for influenza virus H5 hemagglutinin. Biochemical andNakauchi M, Nagata N, Takayama I, Saito S, Kubo H,

biophysical research communications, 498(4):758-763,

Kaida A, Oba K, Odagiri T, Kageyama T. Propagation

2018.
22.

Sun, L., Kono, N., Toh, H., Xue, H., Sano, K., Suzuki,

Airway HBEC3-KT Epithelial Cells. Viruses. 11(3),T., Ainai, A., Orba, Y., Yamagishi, J., Hasegawa, H.,

E216, 2019.

Takahashi, Y., Itamura, S., Ohnishi, K. Identification ofNakauchi M, Takayama I, Takahashi H, Semba S, Saito

MouseS, Kubo H, Kaida A, Oba K, Nagata S, Odagiri T,

Next-Generation Sequencing. J. Vis. Exp. (145),

Kageyama T. Development of real-time fluorescente58804, 2019.

transcription

loop-mediatedisothermal

23.

and

Human

Antibody

Repertoires

byHiradate Y, Sasaki E, Momose H, Asanuma H,

amplification assays for rhinovirus detection. J Med

Furuhata K, Takai M, Aoshi T, Yamada H, Ishii KJ,Virol. 91:1232-1238, 2019.

Tanemura K, Mizukami T, Hamaguchi I. Development

Takayama I, Nakauchi M, Takahashi H, Oba K, Sembaof screening method for intranasal influenza vaccine

S, Kaida A, Kubo H, Saito S, Nagata S, Odagiri T,and adjuvant safety in preclinical study. Biologicals,Kageyama T. Development of real-time fluorescent

Sep;55:43-52, 2018.

reversetranscription

amplification

assay

loop-mediatedwithquenchingisothermal
primerforinfluenza virus and respiratory syncytial virus. J VirolMethods. 267:53-58, 2019.
18.

21.

Efficient protection of micetetramerization improves target breadth but not peak

reverse17.

Sato K, Takahashi Y, Adachi Y, Asanuma H, Ato M,
Tashiro M, Itamura S.

of Rhinovirus C in Differentiated Immortalized Human

16.

20.

human infection. Microbiol Immunol. 63(1): 21-31,

Setiawaty V, Pangesti KNA, Hasegawa H. IgA

15.

Shimasaki N, Okaue A, Kikuno R, Shinohara K.

Saito S, Takayama I, Nakauchi M, Nagata S, Oba K,latest H9N2 influenza viruses capable of causing14.

coronavirus. J Virol Methods. 258:41-48, 2018.

Shirato K, Semba S, El-Kafrawy S, Hassen A, Tolah A,Takayama I, Kageyama T, Notomi T, Kamitani W,Matsuyama S, Azhar E. Development of fluorescent
reversetranscription

loop-mediatedisothermal

amplification (RT-LAMP) using quenching probes forthe detection of the Middle East respiratory syndrome